XASX
TGH
Market cap5mUSD
Oct 09, Last price
0.02AUD
1D
0.00%
1Q
5.88%
IPO
-90.77%
Name
Terragen Holdings Ltd
Chart & performance
P/E
—
P/S
5.90
EPS
—
Div yield, %
—
Shrs. gr., 5y
26.03%
Rev. gr., 5y
-17.08%
Revenues
1m
-11.34%
Net income
-4m
L+0.74%
CFO
-3m
L+11.46%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Coolum Beach, Australia, and founded in 1996, Terragen Holdings Limited specializes in the innovation, production, and commercialization of biological products for the agricultural sector. The company distributes its solutions throughout Australia and New Zealand, offering key products such as Mylo, an animal feed additive, and Great Land, a liquid biological treatment formulated to improve soil quality and characteristics.
Key people
Michael Barry
Non-Executive Chairman of the Board · since 2023
Roger Mcpherson
Chief Financial Officer, Company Secretary · since 2025
Matthew Whyte
Chief Financial Officer, Company Secretary · since 2024
Richard Norton
Chief Executive Officer, Managing Director · since 2024
Paul Grave
General Manager - New Zealand · since 2021
Michele Allan
Non-Executive Director · since 2023
Non-Executive Director · since 2024
Scobie Ward
Non-Executive Director · since 2023
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||